Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Caladrius Biosciences Inc...

    NASDAQ: CLBS · Real-Time Price · USD
    0.43
    -0.08 (-16.05%)
    At close: Sep 15, 2022, 6:00 AM

    Caladrius Biosciences Statistics

    Share Statistics

    Caladrius Biosciences has 7.86M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 7.86M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 6.51M

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -0.47 and the forward PE ratio is null. Caladrius Biosciences's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.47

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.14

    P/FCF Ratio

    n/a
    		 -0.58

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Caladrius Biosciences has an Enterprise Value (EV) of -81.98M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 2.83

    EV / EBIT

    n/a
    		 3.69

    EV / FCF

    n/a
    		 3.68

    Financial Position

    The company has a current ratio of 21, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 21

    Quick Ratio

    n/a
    		 21

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is -29.85% and Return on Invested Capital is -29.85%.

    Return on Equity

    n/a
    		 -29.85%

    Return on Assets

    n/a
    		 -28.31%

    Return on Invested Capital

    n/a
    		 -29.85%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,017,259.26

    Employee Count

    n/a
    		 27

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -1.51M

    Effective Tax Rate

    n/a
    		 5.2%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 0.91, so Caladrius Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.91

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 0.52

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 28.42

    Average Volume (20 Days)

    n/a
    		 n/a

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -29.05M

    Operating Income

    n/a
    		 -28.97M

    Net Income

    n/a
    		 -27.47M

    EBITDA

    n/a
    		 -28.92M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -1.78
    Full Income Statement

    Balance Sheet

    The company has 94.97M in cash and 0 in debt, giving a net cash position of 94.97M.

    Cash & Cash Equivalents

    n/a
    		 94.97M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -453.02M

    Total Assets

    n/a
    		 85.88M

    Working Capital

    n/a
    		 71.59M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -22.25M and capital expenditures -60K, giving a free cash flow of -22.3M.

    Operating Cash Flow

    n/a
    		 -22.25M

    Capital Expenditures

    n/a
    		 -60K

    Free Cash Flow

    n/a
    		 -22.3M

    FCF Per Share

    n/a
    		 -1.44
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    CLBS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -211.37%

    FCF Yield

    n/a
    		 -171.65%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for CLBS.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Sep 15, 2022. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Sep 15, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -5.6

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist